Genetic testing promises to put the ability to decide about our life choices in our hands, as well as help solve crucial health problems by preventing the insurgence of diseases. But what happens when these exams are managed by private companies in a free market? Public communication and marketing have proven to be crucial battlefields on which companies companies need to engage in order to emerge. This issue of JCOM tries to shed some light on the communication and marketing practices used by private companies that sell direct-to-consumer genetic testing, from single genetic mutations to whole genome sequencing.
Associated Projects
TEAM MEMBERS
Alessandro Delfanti
Author
SISSA
Citation
ISSN
:
1824-2049
Publication Name:
Journal of Science Communication
Volume:
10
Number:
3
If you would like to edit a resource, please email us to submit your request.